Esperion Therapeutics
ESPR
#6675
Rank
โ‚น62.46 B
Marketcap
โ‚น243.22
Share price
-4.57%
Change (1 day)
101.49%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Market cap: โ‚น62.46 Billion

As of April 2026 Esperion Therapeutics has a market cap of โ‚น62.46 Billion. This makes Esperion Therapeutics the world's 6675th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น62.46 B-27.35%
2025โ‚น85.97 B123.09%
2024โ‚น38.53 B36.15%
2023โ‚น28.30 B-25.48%
2022โ‚น37.98 B67.6%
2021โ‚น22.66 B-54.01%
2020โ‚น49.27 B-57.86%
2019โ‚น116.92 B35.52%
2018โ‚น86.28 B-21.66%
2017โ‚น110.13 B473.95%
2016โ‚น19.18 B-42.39%
2015โ‚น33.30 B-36.12%
2014โ‚น52.14 B300.4%
2013โ‚น13.02 B

End of Day market cap according to different sources

On Mar 31st, 2026 the market cap of Esperion Therapeutics was reported to be:

โ‚น65.45 Billion
by Nasdaq info icon info icon
โ‚น65.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚น15.133 T 24,129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚น7.657 T 12,159.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
โ‚น196.24 B 214.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
โ‚น64.74 B 3.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น422.52 B 576.46%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น1.025 T 1,542.40%๐Ÿ‡บ๐Ÿ‡ธ USA